Diebold Nixdorf announced a 5% year-over-year revenue increase for Q3 2026, driven by strong double-digit growth in its Retail segment. Gross profit rose slightly under both GAAP and non-GAAP measures, reaching $247.2 million and $250.4 million respectively. The company highlighted strategic wins in Banking and Retail sectors, reinforcing its long-term growth prospects. Additionally, the board authorized a new $250 million share repurchase program and updated its full-year 2026 financial outlook, signaling confidence in future performance.
Diebold Nixdorf's Q3 2026 results provide context for readers. For those following the Technology sector, 70 of 150 US stocks rose and 72 fell on Pluang as of Oct 28, 2026 17:11 WIB. Notable movers include CIFR at USD 8.72 with 90% buy orders, GRMN at USD 295.99 with 100% sell orders, and IREN at USD 28.07 with 63% sell orders.
Arcutis Biotherapeutics has appointed Dr. Rob Scott, a seasoned pharmaceutical executive with over 40 years of experience, to its Board of Directors. Dr. Scott's expertise in developing and securing approvals for innovative medicines, including derma...
Air Canada and CAE announced the opening of applications on November 1, 2026, for the 2027 Commandante-Judy-Cameron scholarships. These scholarships support up to eight Canadian women pursuing professional pilot or aircraft maintenance technician tra...
The Legacy Lab by Team One released its 2026 Legacy Makers 100 list, identifying brands consumers trust to have their best interests at heart and remain relevant long-term. St. Jude Children's Research Hospital topped the list for the second year. Th...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Grabar Law Office is investigating claims against officers and directors of Erasca, Planet Fitness, PROCEPT BioRobotics, and The Simply Good Foods Company for alleged breaches of fiduciary duties. The investigations focus on misleading statements and...
